| Dr Abby Renee Lochmann-bailkey, MD | |
|
700 S Park St, Madison, WI 53715-1830 | |
| (608) 260-2900 | |
| (608) 260-2977 |
| Full Name | Dr Abby Renee Lochmann-bailkey |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 11 Years |
| Location | 700 S Park St, Madison, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366886806 | NPI | - | NPPES |
| 1366886806 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 63264-20 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health St Mary's Hospital - Madison | Madison, WI | Hospital |
| Ssm Health St Mary's Hospital - Janesville | Janesville, WI | Hospital |
| Ssm Health St Clare Hospital - Baraboo | Baraboo, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dean Health Systems Inc | 7012827983 | 1068 |
News Archive
A group of children who underwent fusion surgery for spondylolisthesis in the lumbar spine 30 years ago showed a clear reduction in back pain when followed up seven years later. A new study of these patients as adults has found that the benefits have lasted, reveals research from the Sahlgrenska Academy and Sahlgrenska University Hospital presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 2 days ago
| Entity Name | Dean Health Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053358846 PECOS PAC ID: 7012827983 Enrollment ID: O20031105000584 |
News Archive
A group of children who underwent fusion surgery for spondylolisthesis in the lumbar spine 30 years ago showed a clear reduction in back pain when followed up seven years later. A new study of these patients as adults has found that the benefits have lasted, reveals research from the Sahlgrenska Academy and Sahlgrenska University Hospital presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 2 days ago
| Entity Name | Reedsburg Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891796710 PECOS PAC ID: 9830008259 Enrollment ID: O20031208000083 |
News Archive
A group of children who underwent fusion surgery for spondylolisthesis in the lumbar spine 30 years ago showed a clear reduction in back pain when followed up seven years later. A new study of these patients as adults has found that the benefits have lasted, reveals research from the Sahlgrenska Academy and Sahlgrenska University Hospital presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 2 days ago
| Entity Name | Stoughton Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679558647 PECOS PAC ID: 7012825706 Enrollment ID: O20040402001358 |
News Archive
A group of children who underwent fusion surgery for spondylolisthesis in the lumbar spine 30 years ago showed a clear reduction in back pain when followed up seven years later. A new study of these patients as adults has found that the benefits have lasted, reveals research from the Sahlgrenska Academy and Sahlgrenska University Hospital presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abby Renee Lochmann-bailkey, MD 700 S Park St, Madison, WI 53715-1830 Ph: (608) 260-2900 | Dr Abby Renee Lochmann-bailkey, MD 700 S Park St, Madison, WI 53715-1830 Ph: (608) 260-2900 |
News Archive
A group of children who underwent fusion surgery for spondylolisthesis in the lumbar spine 30 years ago showed a clear reduction in back pain when followed up seven years later. A new study of these patients as adults has found that the benefits have lasted, reveals research from the Sahlgrenska Academy and Sahlgrenska University Hospital presented this week at the International Society of Orthopaedic Surgery and Traumatology (SICOT) annual international conference in Gothenburg.
Genomics researchers analyzing a rare, serious immunodeficiency disease in children have discovered links to a gene crucial to the body's defense against infections. The finding may represent an inviting target for drugs to treat common variable immunodeficiency (CVID).
A major research company with expertise in managing clinical trials is partnering with the University of Colorado's Anschutz Medical Campus to more efficiently bring the latest stem cell discoveries from the laboratory to the patient.
Nymox Pharmaceutical Corporation announced today that it has been awarded a grant of $244,479.25 from the U.S Government under the Qualifying Therapeutic Discovery Project for its ongoing Phase III clinical trial program for NX-1207 for the treatment of benign prostatic hyperplasia (BPH). The grant was the maximum allowable for an individual development program.
Full risk or preferably the safe option? Based on the neuronal activity in the prefrontal cortex of the brain, it is possible to predict what action will be chosen next: If the activity of specific neurons remains low, a risk will be taken again at the next opportunity.
› Verified 2 days ago
Prof. Marvin Lyle Birnbaum, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3330 University Ave, Suite 300, Madison, WI 53705 Phone: 608-263-9641 Fax: 608-265-4429 | |
Yingyu Gao, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-263-6400 | |
Dr. Sam Joseph Lubner, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 600 Highland Ave, Madison, WI 53792 Phone: 608-265-1700 | |
Randy S Heidel, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 20 S Park St, Madison, WI 53715 Phone: 608-287-2250 Fax: 608-287-2438 | |
Benjamin Kleiber, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 700 S Park St, Dean & St. Mary's Outpatient Center, Madison, WI 53715 Phone: 608-260-2900 Fax: 608-260-2956 | |
N Thomas Casper, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 3102 Meriter Way, Madison, WI 53719 Phone: 608-417-8800 | |
Philip Tepper Cohen, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 5154 Juneau Rd, Madison, WI 53705 Phone: 608-441-2512 Fax: 608-441-2512 |